INX-315

For research use only. Not for therapeutic Use.

  • CAT Number: I040154
  • CAS Number: 2745060-92-6
  • Molecular Formula: C19H21N7O3S
  • Molecular Weight: 427.48
  • Purity: ≥95%
Inquiry Now

INX-315 (Cat No.: I040154) is a novel small-molecule compound being investigated for its potential in cancer therapy. It is designed to target specific molecular pathways involved in tumor progression, particularly those that regulate cell growth, survival, and metastasis. INX-315 works by modulating key signaling networks, potentially enhancing the efficacy of existing cancer treatments and overcoming resistance mechanisms. Ongoing preclinical studies focus on understanding its mechanism of action, with hopes of positioning INX-315 as a valuable therapeutic option for solid tumors and hematologic cancers.


CAS Number 2745060-92-6
Synonyms

4-[(12-oxospiro[1,3,5,10,11-pentazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1′-cyclohexane]-4-yl)amino]benzenesulfonamide

Molecular Formula C19H21N7O3S
Purity ≥95%
InChI InChI=1S/C19H21N7O3S/c20-30(28,29)14-6-4-13(5-7-14)22-18-21-11-12-10-15-24-25-17(27)19(8-2-1-3-9-19)26(15)16(12)23-18/h4-7,10-11,24H,1-3,8-9H2,(H,25,27)(H2,20,28,29)(H,21,22,23)
InChIKey KGJVKYSVVOQPDL-UHFFFAOYSA-N
SMILES C1CCC2(CC1)C(=O)NNC3=CC4=CN=C(N=C4N23)NC5=CC=C(C=C5)S(=O)(=O)N
Reference

[1]. Dietrich C, et al. INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors. Cancer Discov. 2023 Dec 4.
[Content Brief]

Chemistry Calculators Dilution Calculator
In vivo Formulation Calculator
Molarity Calculator
Molecular Weight Calculator
Reconstitution Calculator

Request a Quote